The BDLF2 protein of Epstein-Barr virus is a type II glycosylated envelope protein whose processing is dependent on coexpression with the BMRF2 protein

Virology

Volumn 383, Issue 1, 2009, Pages 162-167

  Gore, Mindy ^a   Hutt Fletcher, Lindsey M ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

BDLF2; BMRF2; Envelope glycoproteins; Epstein Barr virus; Glycoprotein processing

Indexed keywords

ENVELOPE PROTEIN; GLYCOPROTEIN; GLYCOPROTEIN BMRF 2; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; BDLF 2 GENE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE; GENE LOCATION; NONHUMAN; PRIORITY JOURNAL; VIRION; WESTERN BLOTTING;

CELL LINE; HERPESVIRUS 4, HUMAN; HUMANS; MEMBRANE GLYCOPROTEINS; MOLECULAR WEIGHT; PROTEIN BINDING; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS; VIRION;

HUMAN HERPESVIRUS 4;

EID: 57049144773     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.10.010     Document Type: Article

References (22)

1. Baer R., Bankier A.T., Biggin M.D., Deininger P.L., Farrell P.J., Gibson T.J., Hatfull G., Hudson G.S., Satchwell S.C., Seguin C., Tuffnell P.S., and Barrell B.G. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310 (1984) 207-211
2. Borza C.M., Morgan A.J., Turk S.M., and Hutt-Fletcher L.M. Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J. Virol. 78 (2004) 5007-5014
3. Duckert P., Brunak S., and Blom N. Prediction of proprotein convertase cleavage sites. Protein Eng. Des. Sel. 17 (2004) 107-112
4. Gill M.B., Edgar R., May J.S., and Stevenson P.G. A gamma-herpesvirus glycoprotein complex manipulates actin to promote viral spread. PLos ONE 3 (2008) e1808
5. Johannsen E., Luftig M., Chase M.R., Weicksel S., Cahir-McFarland E., Illanes D., Sarracino D., and Kieff E. Proteins of purified Epstein-Barr virus. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 16286-16291
6. Lake C.M., Molesworth S.J., and Hutt-Fletcher L.M. The Epstein-Barr virus (EBV) gN homolog BLRF1 encodes a 15 kilodalton glycoprotein that cannot be authentically processed unless it is co-expressed with the EBV gM homolog BBRF3. J. Virol. 72 (1998) 5559-5564
7. Li Q.X., Turk S.M., and Hutt-Fletcher L.M. The Epstein-Barr virus (EBV) BZLF2 gene product associates with the gH and gL homologs of EBV and carries an epitope critical to infection of B cells but not of epithelial cells. J. Virol. 69 (1995) 3987-3994
8. Maley F., Trimble R.B., Tarentino A.L., and Plummer Jr. T.H. Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal. Biochem. 180 (1989) 195-204
9. May J.S., de Lima B.D., Colaco S., and Stevenson P.G. Intercellular gamma-herpesvirus dissemination involves co-ordinated intracellular membrane protein transport. Traffic 6 (2005) 780-793
10. May J.S., Walker J., Colaco S., and Stevenson P.G. The murine gammaherpesvirus 68 ORF27 gene product contributes to intercellular viral spread. J. Virol. 79 (2005) 5059-5068
11. McShane M.P., and Longnecker R. Cell-surface expression of a mutated Epstein-Barr virus glycoprotein B allows fusion independent of other viral proteins. Proc. Natl. Acad. Sci. U. S. A. 101 (2004) 17474-17479
12. Molesworth S.J., Lake C.M., Borza C.M., Turk S.M., and Hutt-Fletcher L.M. Epstein-Barr virus gH is essential for penetration of B cell but also plays a role in attachment of virus to epithelial cells. J. Virol. 74 (2000) 6324-6332
13. Moss B., Elroy-Stein O., Mizukami T., Alexander W.A., and Fuerst T.R. New mammalian expression vectors. Nature 348 (1990) 91-92
14. Niwa H., Yamamura K., and Miyazaki J. Efficient selection for high-expression tansfectants with a novel eukaryotic vector. Gene 108 (1991) 193-199
15. Oda T., Imai S., Chiba S., and Takada K. Epstein-Barr virus lacking glycoprotein gp85 cannot infect B cells and epithelial cells. Virology 276 (2000) 52-58
16. Takada K. Cross-linking of cell surface immunoglobulin induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33 (1984) 27-32
17. Tugizov S.M., Berline J.W., and Palefsky J.M. Epstein-Barr virus infection of polarized tongue and nasopharyngeal epithelial cells. Nature Med. 9 (2003) 307-314
18. Virgin H.W.I., Latreille P., Wamsley P., Hallsworth K., Weck K.E., Dal Canto A.J., and Speck S.H. Complete sequence and analysis of murine gammaherpesvirus 68. J. Virol. 71 (1997) 5894-5904
19. Wu L., and Hutt-Fletcher L.M. Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion. Virology 363 (2007) 148-155
20. Xiao J., Palefsky J.M., Herrera R., and Tugizov S.M. Characterization of the Epstein-Barr virus glycoprotein BMRF2. Virology 359 (2007) 382-396
21. Xiao J., Palefsky J.M., Herrera R., Berline J., and Tugizov S.M. The Epstein-Barr virus BMRF-2 protein facilitates attachment to oral epithelial cells. Virology 370 (2008) 430-442
22. Yaswen L.R., Stephens E.B., Davenport L.C., and Hutt-Fletcher L.M. Epstein-Barr virus glycoprotein gp85 associates with the BKRF2 gene product and is incompletely processed as a recombinant protein. Virology 195 (1993) 387-396